Klacid Susp.125 125 mg/5ml

البلد: الأردن

اللغة: الإنجليزية

المصدر: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

العنصر النشط:

Clarithromycin 125 mg/5ml

متاح من:

مستودع أدوية أبوشيخة - Abu Sheikha Drug Store

ATC رمز:

J01FA09

INN (الاسم الدولي):

Clarithromycin 125 mg/5ml

جرعة:

125 mg/5ml

الوحدات في الحزمة:

60ml

المصنعة من قبل:

AbbVie S.r.l/Italy (ايطاليا)

ملخص المنتج:

4.68 :سعر الجمهور + الضريبة

نشرة المعلومات

DESCRIPTION AND COMPOSITION
_KLACID 250 MG TABLETS:_ A yellow, ovaloid film-coated tablet
containing 250 mg of
clarithromycin.
_KLACID 125MG/5ML GRANULES FOR ORAL SUSPENSION: _White to off - white
granules for
reconstitution. After mixing each 5 ml of suspension contains 125 mg
clarithromycin.
CLINICAL PARTICULARS
THERAPEUTIC INDICATIONS
Consideration should be given to official guidance on the appropriate
use of antibacterial
agents.
Klacid 250 mg Tablets is indicated in adults and children 12 years and
older.
Klacid Granules 125 mg/5ml is indicated in children 6 months to 12
years.
_ALL PHARMACEUTICAL FORMS_:
Indicated for treatment of infections caused by susceptible organisms.
Indications include:

Lower respiratory tract infections for example, acute and chronic
bronchitis, and pneumonia

Upper respiratory tract infections for example, sinusitis and
pharyngitis.

skin and soft tissue infections of mild to moderate severity, for
example folliculitis, cellulitis
and erysipelas
_KLACID 250 MG TABLETS: _

Clarithromycin is appropriate for initial therapy in community
acquired respiratory infections
and has been shown to be active _in vitro_ against common and atypical
respiratory pathogens as
listed in the microbiology section.

Clarithromycin in the presence of acid suppression effected by
omeprazole or lansoprazole_ _
is also indicated for the eradication of _H. pylori_ in patients with
duodenal ulcers. See Dosage
and Administration section.
Clarithromycin is usually active against the following organisms in
vitro:
Gram-positive Bacteria: _Staphylococcus aureus_ (methicillin
susceptible); _Streptococcus _
_pyogenes_ (Group A beta-haemolytic streptococci); alpha-haemolytic
streptococci (viridans
group_); Streptococcus (Diplococcus) pneumoniae; Streptococcus
agalactiae; Listeria _
_monocytogenes_.
Gram-negative Bacteria: _Haemophilus influenzae; Haemophilus
parainfluenzae; Moraxella _
_(Branhamella) catarrhalis; Neisseria gonorrhoeae; Legionella
pneumophila; Bordetella _
_pertussis; Helicobacter p